Abstract
Parathyroid carcinoma (PC) is a very rare head-neck malignancy. Because the symptoms of parathyroid carcinoma are similar to those of benign causes of hyperparathyroidism, it may be not easy to detect it before surgery. The management of PC after initial surgery will be perplexing because of the adequacy of surgery. We wish to describe the difficulties encountered throughout treatment using a literature review. We conducted a retrospective analysis of individuals with parathyroid carcinoma who had treatment at our department between 2017 and 2022. We gathered data on the clinical profile, investigations, management of hypercalcemia, surgical techniques, histopathological features, adjuvant therapy, and outcomes. We treated three patients with parathyroid carcinoma: Two patients with inferior parathyroid carcinoma and one with superior parathyroid carcinoma. Generalized weakness and bony pain are the predominant symptoms. In all cases, the tumor was located using 99Tc MIBI / SPECT scintigraphy and Ultrasonography. Hemithyroidectomy and tumor excision were done as the surgery of choice. All are disease-free at the 12th-month follow-up. We suggested that parathyroid hormone testing be performed in all bony fibrous lesions to rule out hyperparathyroidism. PC is a likely diagnosis when there is noticeable throat swelling, elevated PTH levels greater than 400 IU/L, and serum calcium levels greater than 15 mg/dL.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12070-023-03499-6/MediaObjects/12070_2023_3499_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12070-023-03499-6/MediaObjects/12070_2023_3499_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12070-023-03499-6/MediaObjects/12070_2023_3499_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12070-023-03499-6/MediaObjects/12070_2023_3499_Fig4_HTML.jpg)
Similar content being viewed by others
References
Wei CH, Harari A (2012) Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol 13(1):11–23. https://doi.org/10.1007/s11864-011-0171-3
Schantz A, Castleman B (1973) Parathyroid carcinoma. A study of 70 cases. Cancer 31(3):600–605
Lenschow C, Schrägle S, Kircher S, Lorenz K, Machens A, Dralle H, Riss P, Scheuba C, Pfestroff A, Spitzweg C, Zielke A (2022) Clinical presentation, treatment, and outcome of parathyroid carcinoma: results of the NEKAR retrospective international multicenter study. Ann Surg 275(2):e479–e487. https://doi.org/10.1097/SLA.0000000000004144
Wang P, Xue S, Wang S, Lv Z, Meng X, Wang G, Meng W, Liu J, Chen G (2017) Clinical characteristic and treatment outcomes of parathyroid carcinoma: a retrospective review of 234 cases. Oncol Lett 14(6):7276–7282. https://doi.org/10.3892/ol.2017.7076
Landry CS, Wang TS, Asare EA et al (2017) Parathyroid. In: Amin MB (ed) AJCC cancer staging manual. Springer, New York
Mohebati A, Shaha A, Shah J (2012) Parathyroid carcinoma: challenges in diagnosis and treatment. Hematol Oncol Clin North Am 26(6):1221–1238. https://doi.org/10.1016/j.hoc.2012.08.009
Saleem M, Iftikhar H (2019) Stones, bones, groans, and psychic moans: primary hyperparathyroidism presenting as surgical emergency. Cureus. https://doi.org/10.7759/cureus.4989
Ricci G, Assenza M, Barreca M, Liotta G, Paganelli L, Serao A, Tufodandria G, Marini P (2012) Parathyroid carcinoma: the importance of high clinical suspicion for a correct management. Int J Surg Oncol. https://doi.org/10.1155/2012/649148
Fingeret AL (2021) Contemporary evaluation and management of parathyroid carcinoma. JCO Oncol Pract 17(1):17–21. https://doi.org/10.1200/JOP.19.00540
Shah R, Gosavi V, Mahajan A, Sonawane S, Hira P, Kurki V, Bal M, Sathe P, Pai P, D’CrD’CruzUchino S, Garale MN, Patil V, Lila A, Shah N, Bandgar T (2021) PreopePreoperativetiven of parathyroid carcinoma in an Asian Indian cohort. Head Neck 43(7):2069–2080. https://doi.org/10.1002/hed.26677
Liu J, Zhan WW, Zhou JQ, Zhou W (2020) Role of ultrasound in diagnosing parathyroid carcinoma and benign parathyroid lesions. Clin Radiol 75(3):179–184. https://doi.org/10.1016/j.crad.2019.10.004
Kassahun WT, Jonas S (2011) Focus on parathyroid carcinoma. Int J Surg 9(1):13–19. https://doi.org/10.1016/j.ijsu.2010.09.003
Caudill R, Saltzman D, Gaum S, Granite E (1977) Possible relationship of primary hyperparathyroidism and fibrous dysplasia: report of case. J Oral Surg 35(6):483–490
Turcu AF, Clarke BL (2013) Fibrous dysplasia of bone associated with primary hyperparathyroidism. Endocr Pract 19(2):226–230. https://doi.org/10.4158/EP12301.OR
Arik N, Biriken D, Akpolat T, Sungur C, Coşkun C, Başoğlu T, Keskin M, Sahin M, Toller MO (1996) Severe hyperparathyroidism associated with fibrous dysplasia: a case report. Nephron 74(2):481–482. https://doi.org/10.1159/000189380
Diallo I, Fall CA, Ndiaye B et al (2016) Primary hyperparathyroidism and pancreatitis: a rare association with multiple facets. Int Sch Res Notices. https://doi.org/10.1155/2016/7294274
Sethi J, Kumar V, Rathi M, Gupta KL (2018) Acute kidney injury associated with hypercalcaemic crisis in a patient with primary hyperparathyroidism. BMJ Case Rep. https://doi.org/10.1136/bcr-2018-225235
Wong KK, Fig LM, Gross MD, Dwamena BA (2015) Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun 36(4):363–375. https://doi.org/10.1097/MNM.0000000000000262
Tian Y, Tanny ST, Einsiedel P et al (2018) Four-dimensional computed tomography: clinical impact for patients with primary hyperparathyroidism. Ann Surg Oncol 25(1):117–121. https://doi.org/10.1245/s10434-017-6115-9
Leonard-Murali S, Ivanics T, Kwon DS, Han X, Steffes CP, Shah R (2021) Local resection versus radical surgery for parathyroid carcinoma: a national cancer database analysis. Europ J Surg Oncol 47(11):2768–2773. https://doi.org/10.1016/j.ejso.2021.06.026
Young S, Wu JX, Li N, Yeh MW, Livhits MJ (2016) More extensive surgery may not improve survival over parathyroidectomy alone in parathyroid carcinoma. Ann Surg Oncol 23(9):2898–2904
Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Perrier ND (2019) Risk of distant metastasis in parathyroid carcinoma and its effect on survival: a retrospective review from a high-volume center. Ann Surg Oncol 26(11):3593–3599
Akirov A, Asa SL, Larouche V, Mete O, Sawka AM, Jang R, Ezzat S (2019) The Clinicopathological spectrum of parathyroid carcinoma. Front Endocrinol (Lausanne) 23(10):731. https://doi.org/10.3389/fendo.2019.00731
Hu Y, Liao Q, Cao S, Gao X, Zhao Y (2016) Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis. Endocrine 54(3):612–619. https://doi.org/10.1007/s12020-016-0997-3
Witteveen JE, van Thiel S, Romijn JA, Hamdy NA (2013) Hungry bone syndrome: still a challenge in the postoperative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol 168(3):R45-53. https://doi.org/10.1530/EJE-12-0528
Mayilvaganan S, VijayaSarathi HA, Shivaprasad C (2017) Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism. Indian J Endocrinol Metab 21(1):76–79. https://doi.org/10.4103/2230-8210.196023
Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Perrier ND (2017) Prognostic scoring system to risk stratify parathyroid carcinoma. J Am Coll Surg 224(5):980–987. https://doi.org/10.1016/j.jamcollsurg.2017.01.060
Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS, van Heerden JA, Thompson GB, Lloyd RV (2003) Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 98(11):2378–2384. https://doi.org/10.1002/cncr.11819
Limberg J, Stefanova D, Ullmann TM, Thiesmeyer JW, Bains S, Beninato T, Zarnegar R, Fahey TJ, Finnerty BM (2021) The use and benefit of adjuvant radiotherapy in parathyroid carcinoma: a National Cancer Database Analysis. Ann Surg Oncol 28(1):502–511. https://doi.org/10.1245/s10434-020-08825-8
Ferraro V, Sgaramella LI, Di Meo G, Prete FP, Logoluso F, Minerva F, Noviello M, Renzulli G, Gurrado A, Testini M (2019) Current concepts in parathyroid carcinoma: a single Centre experience. BMC Endocr Disord 19(Suppl 1):46. https://doi.org/10.1186/s12902-019-0368-1
Angelousi A, Dimitriadis GK, Zografos G, Nölting S, Kaltsas G, Grossman A (2017) Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies. Endocr Relat Cancer 24(6):R239–R259. https://doi.org/10.1530/ERC-16-0542
Author information
Authors and Affiliations
Contributions
RK: conception, data collection, final editing, approval; SM: manuscript writing, data collection, literature review; CAS: data collection, manuscript editing; SA: data collection, final manuscript editing; SP: data collection, manuscript editing; PS: data collection, manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
No.
Source of support
No.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mani, S., Kumar, R., Singh, C.A. et al. Parathyroid carcinoma: lessons from a rare malignancy of head and neck—a case series. Indian J Otolaryngol Head Neck Surg 75, 809–816 (2023). https://doi.org/10.1007/s12070-023-03499-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-023-03499-6